Laboratory Corporation of America Holdings at Robert W Baird Global Healthcare Conference Transcript
Okay. Good morning, everyone. This is Eric Coldwell. I'm Baird's Healthcare Supply Chain and Pharma Services analyst, and it's our pleasure today to have LabCorp with us presenting in the room. As you can see, we have Clarissa Willett, VP of IR; Glenn Eisenberg, EVP and CFO; and also Adam Schechter, Chairman and CEO.
To get started, we're going to have Adam kick us off with a few comments, and then we'll go straight into the fireside chat. Adam?
Yes. Thank you, Eric. It's good to see you, and we appreciate you having us here today. I wish we could be with you in person. Obviously, we can't do that at the moment. But we're committed to talking with you, to talking about LabCorp, the issues that we face, but also the great strides that we've made as we've gone through COVID-19. And as we continue to implement our overall strategy.
I'll be making
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |